AI Summary
Malaysian pharmaceutical company Pharmaniaga Bhd has exited PN17 status after successfully implementing its regularization plan. This involved a capital reduction of RM520 million, effectively wiping out accumulated losses. The completion marks a significant milestone for the company's financial recovery.
Read the original article
This article has been processed for multi-language support.
Embedded View
Related Articles
B
Business : CIMB: Portion Of Malaysiaâs Semiconductor Exports May Qualify For US Tariff Exemption
B
B
Business : Business Events Instrumental To Achieve Tourism Targets Under 13MP -- Ahmad Zahid
B
B
General : Sunway Medical Centre Brings Core Health Services Closer To Public Via Life Moves Festival 2025
B
B
Business : Malaysia Airlines' "On-time Performance" For Domestic Flights At 85.3 Pct As Of May 2025 -- MOT
B